Verdict Medical Devices

Cognixion and Pupil Lab partner to advance neural-visua...

Brain-computer interface (BCI) technology developer Cognixion, and eye-tracking ...

Treating heart defects with less invasive options

Innovative cardiac devices are changing how we treat heart defects, offering les...

Guardant Health’s MCD test earns FDA breakthrough desig...

Guardant Health's Shield multi-cancer detection (MCD) test has secured the US Fo...

French ANSM authorises FineHeart’s device trial for hea...

The French National Agency for the Safety of Medicines and Health Products (ANSM...

EU votes to ‘freeze out’ China from medical device proc...

Reports have emerged that the European Union (EU) has voted to ban Chinese compa...

Johnson & Johnson MedTech introduces automated system f...

Johnson & Johnson MedTech has introduced the KINCISE 2 Surgical Automated System...

Zest launches early dementia screening test

Zest has unveiled a new app-based cognitive test designed to screen for the earl...

University of Turku develops probe to visualise breast ...

Finland’s University of Turku researchers have developed a fluorescent probe for...

Neural data at risk – is the US ready to act?

Brain-computer interface (BCI) technologies are advancing rapidly, and – as with...

ASCO25: PanGIA Biotech’s AI-based urine test for prosta...

With early detection of prostate cancer recognised as a critical part in reducin...

GE HealthCare and Kalbe open CT scanner production faci...

GE HealthCare and PT Kalbe Farma Tbk (Kalbe) have launched the first computed to...

Neuralink secures $650m in Series E to advance brain im...

Neuralink has secured $650m in a Series E financing round, marking a milestone i...

Vantive to invest $1bn for kidney care advancement  

Vantive is investing $1bn towards advancing its kidney care and vital organ supp...

Biocartis’ EGFR Mutation Test gains IVDR Class C CDx ce...

Biocartis’ Idylla EGFR Mutation Test has secured the EU Technical Documentation ...

EU Shield consortium launches to cut pancreatic cancer ...

A new EU consortium has launched with the aim to reduce pancreatic cancer mortal...

ASCO 2025: Harbinger Health reports clinical data of bl...

Harbinger Health has reported clinical data at the American Society of Clinical ...

FDA grants breakthrough device status to BiVACOR’s arti...

The US Food and Drug Administration (FDA) has granted breakthrough device design...

NHS rolls out liquid biopsy testing for lung cancer pat...

The UK National Health Service (NHS) England has rolled out a new liquid biopsy ...

Danaher and AstraZeneca to develop diagnostic tools and...

Danaher Corporation has announced a collaboration with AstraZeneca for diagnosti...

Spring Steel: Engineered for performance, designed for ...

Spring steel is undergoing a transformation as high-performance engineering dema...

ASCO25: AI test shown to aid in prostate cancer treatme...

New research has shown that the ArteraAI test can help identify which men with n...

Acclaro Medical secures $23m in Series B funding for sk...

Acclaro Medical has completed a Series B funding round, raising $23m, to spur th...

Moximed announces treatment of first subject in trial o...

Moximed has announced the treatment of the first subject in the MOTION randomise...

HistoSonics’ histotripsy system receives early market a...

HistoSonics' Edison histotripsy system has been granted controlled early limited...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.